Aerocrine listed on the Nordic Exchange

Today, Aerocrine, a Small Cap company within the Health Care sector, has been listed on the Stockholm Stock Exchange. Aerocrine is the 40th* company to join the Nordic Exchange this year.

Aerocrine AB is a clinically based medical technology company that leads the way in the development of devices for monitoring inflammation through the measurement of gaseous markers. The company holds a comprehensive patent portfolio, including eleven approved patents in the USA, with additional patents pending. Aerocrine was founded in 1997 by scientists from the Karolinska Institute in Sweden and has its headquarters in Stockholm.

”It is very gratifying to welcome Aerocrine to the OMX Nordic Exchange. Through the listing of Aerocrine, investors get a valuable addition to the Health Care sector,” says Jenny Rosberg, President of Company Services at OMX.

Photographs will be available on www.omxgroup.com/nordicexchange/marketnews/corporateactions/listings.

A round lot of shares in Aerocrine, whose short name is AERO B, amounts to 500. Aerocrine is a Small Cap company in the Health Care sector.